1. Home
  2. LRN vs LQDA Comparison

LRN vs LQDA Comparison

Compare LRN & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$84.15

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$36.61

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
LQDA
Founded
2000
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
LRN
LQDA
Price
$84.15
$36.61
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$106.75
$40.36
AVG Volume (30 Days)
717.5K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
26.87
51.81
EPS
3.49
N/A
Revenue
$917,734,000.00
$158,320,000.00
Revenue This Year
$6.18
$208.46
Revenue Next Year
$4.74
$27.44
P/E Ratio
$24.03
N/A
Revenue Growth
3.29
1031.18
52 Week Low
$60.61
$11.26
52 Week High
$171.17
$46.67

Technical Indicators

Market Signals
Indicator
LRN
LQDA
Relative Strength Index (RSI) 51.41 50.81
Support Level $79.83 $30.48
Resistance Level $87.64 $46.67
Average True Range (ATR) 2.73 2.34
MACD -0.57 0.63
Stochastic Oscillator 48.96 70.92

Price Performance

Historical Comparison
LRN
LQDA

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: